Dr. Yama A. Abassi is VP of Global Strategic Business Development and Growth at ACEA Biosciences.

He received his undergraduate degree in biochemistry with Honors from State University of New York/Stony Brook in May of 1992 and a PhD degree in Molecular, Cell and Developmental Biology from University of California at Santa Barbara in 1999.

Dr. Abassi joined ACEA Biosciences in 2003 to develop a new technology for real-time cell assessment using microelectronics. Dr. Abassi’s efforts in this field has earned him over 30 publications and 10 patents and has led to the successful development and commercialization of the instruments globally. While at ACEA, he has led both scientific and commercial teams for the Global commercialization, distribution and support of ACEA’s proprietary technology.

企业简介：安捷伦生物（ Agilent Biosciences）是生命科学研究高性能细胞分析平台的开发和商业化先驱。xCELLigence实时细胞分析技术和NovoCyte流式细胞仪广泛运用于新药研发、免疫治疗、疫苗研发、毒理学、安全药理学、质控和基础生命科学等研究。目前，在全球范围内已安装3000多台仪器，并有2000多篇经同行专家评审的高水平学术文献中被引用。

企业网址：https://www.aceabio.com/

其他分享：